Clinical Trials Browser

Terminated × Lymphoma, Large B-Cell, Diffuse × atezolizumab × Clear all

NCT03422523 2022-08-22

ARGO

Phase 2 Terminated

Recurrence, Lymphoma, Large B-Cell, Diffuse